Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2021-09-01
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor

  WINDY CITY TIMES

Community Outraged at AIDS Drug Price Increase
by Bob Roehr
2003-12-31

This article shared 4179 times since Wed Dec 31, 2003
facebook twitter google +1 reddit email


Abbott Laboratories quietly increased the price of ritonavir (Norvir) by 400% Dec. 4, from $1.71 to $8.57 per 100 mg pill. The protease inhibitor (PI) primarily is used in sub-therapeutic doses with other protease inhibitors to delay their clearance by the liver. That means the price increase will be felt widely.

The AIDS community has only slowly become aware of the increase and is reacting with outrage and threats of boycott.

The company has asserted that the increase is a long-overdue price adjustment and reflects the cost of past research when they had to reformulate the compound. It also is not increasing the price to state-run AIDS drug assistance programs (ADAPs).

But many observers are calling it a ploy by Abbott to increase the market share of Kaletra, its other protease inhibitor. Kaletra had been losing ground to other PIs that have recently been approved for sale. This would boost the total cost of other PIs that must use Norvir as booster.

Michael Weinstein, president of the AIDS Healthcare Foundation, noted that even while the price of Norvir was skyrocketing, the price of Kaletra, which uses Norvir to boost its potency, did not increase at all.

'This is purely a marketing ploy to push for a larger market share for Kaletra by driving providers and patients to this cheaper Abbot combination therapy,' Weinstein said. 'The HIV community as a whole should unite and speak out against Abbott's bald-faced greed.'

'Abbott is feeding like a vulture on the bones of our healthcare system,' the AIDS Treatment Activists Coalition (ATAC) said in a flyer they are distributing about the price increase (see Web site www.atac-usa.org/Abbott%20Vulture.pdf).

ATAC, in a letter to Abbott dated Dec. 22, noted that tipranavir, a promising PI under development by Boehringer Ingelheim, uses 400 mg of Norvir daily. If the price increase stands and if tipranavir is approved by the FDA, its price would be about $20,000 a year, several times that of other currently available PIs.

'Abbott has changed the landscape of HIV/AIDS for the worse—is this what it wants to be known for?' asked ATAC. 'We believe that it is in the overall interests of your company to reconsider this shameful and destructive path.'

The HIV Medicine Association called on Abbott to rescind the price increase. 'It is critical that the implications of your actions on access to the majority of treatment regimens available to persons living with HIV/AIDS in the U.S. be given paramount consideration,' it wrote in a Dec. 18 letter to Abbott.

'This increase comes at a time when public programs that provide access to HIV treatment are struggling to keep costs down, and numerous ADAPs have been forced to impose eligibility and formulary restrictions and/or waiting lists.'

Howard Grossman, a physician in New York City with a large HIV practice, said in an e-mail he is 'going to refuse to have Abbott reps in my office and will try to find alternatives to any of their drugs I can.' He is asking the American Academy of HIV Medicine, where he serves as chair of the policy committee, to return funding from Abbott.

'To receive academic or financial support from Abbot Laboratories would be an insult to the many patients who this decision so greatly impacts,' Benjamin Young wrote to the company. The HIV doc and clinical instructor of medicine at the University of Colorado has rescinded any offer to lecture on behalf of the company, attend its advisory committee meetings, or support its research projects.

The London-based AIDSmap quoted one pharmaceutical company research scientist as saying, 'This isn't just an attack on competitors' pricing, it's an attack on their research strategies. Why bother investing in these areas if Abbott has effectively priced you out of the market?'

There is an unconfirmed report that the crusading New York Attorney General, Elliot Spitzer, has initiated an investigation into the price increase.

Grapefruit juice and a number of other drugs have an effect similar to Norvir in terms of slowing the liver's clearance of drugs such a PIs. But none of the alternatives have been studied and so there is no data on whether or how they might be substituted. Given Abbott's price increase, that is an area that researchers are likely to give new attention.


This article shared 4179 times since Wed Dec 31, 2003
facebook twitter google +1 reddit email





Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.


  ARTICLES YOU MIGHT LIKE

Gay News

NATIONAL Carl Bean dies, LGBT History Month, military events, Dykes on Bikes 2021-09-19
- Archbishop Carl Bean—an openly gay former Motown singer, longtime AIDS activist and leader in the LGBTQ church movement—died at age 77, The New York Daily News reported. In a statement entitled "The Giant Sleeps," the Unity ...


Gay News

HHS awards $48M to health centers to expand HIV prevention, treatment 2021-09-16
- On Sept. 16, the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded more than $48 million to 271 HRSA-supported health centers across 26 states, Puerto Rico and ...


Gay News

New safety precautions announced for 30th annual AIDS Run & Walk Chicago Oct. 2 2021-09-08
--From a press release - CHICAGO — AIDS Foundation Chicago (AFC) has announced proof of full vaccination or negative COVID-19 test result within 72 hours of event will be required for all in-person participants for the 30th annual AIDS Run & ...


Gay News

HIV AT 40: Global activist Phill Wilson talks Chicago, the '80s and vaccines 2021-09-01
- Phill Wilson is one of the best-known HIV/AIDS activists/educators around the globe. The Chicago native was the co-founder of the National Black Lesbian and Gay Leadership Forum and the National Task Force on AIDS Prevention. He ...


Gay News

Feds expand insurers' requirements for PrEP coverage 2021-08-26
- Insurers and service-providers have until September to comply with a new federal guidance requiring insurance companies to cover the entire cost of PrEP (pre-exposure prophylaxis) interventions. Many insurers have been ...


Gay News

NATIONAL Ann Arbor ban, Buttigieg, NYC settlement, Gloria Allred 2021-08-22
- Using gay conversion therapy on minors to try to change their sexual orientation or gender identity is now officially banned in Ann Arbor, Michigan, according to MLive.com. "So-called conversion therapy is, of course, an abomination," Mayor ...


Gay News

Chicago Academy's 25th annual AIDS benefit show Sept. 24-25 2021-08-12
- Each year, Chicago Academy for the Arts students produce and perform in a variety show to support HIV/AIDS research and organizations. The 25th Annual AIDS Benefit will take place Sept. 24-25 at The Academy, 1010 W. ...


Gay News

U.S. Conference on HIV/AIDS moves to virtual 2021-08-10
--From a press release - Aug. 10, 2021 - NMAC today announced that the 2021 US Conference on HIV/AIDS will move from an in-person conference to a virtual meeting due to the continued spread of the Delta variant of the Covid ...


Gay News

DaBaby apologizes for 'misinformed' comments about AIDS, LGBTQ people 2021-08-03
- After his headlining sets at Lollapalooza, Governors Ball and Day N Vegas festivals were canceled within 24 hours of each other, rapper DaBaby issued another apology to the LGBTQ community, Variety reported. "Social Media moves so ...


Gay News

PrEP pills to be free for insured people 2021-07-25
- The U.S. government has stated that nearly all health insurers must cover the entire cost of HIV prevention treatments, according to U.S. News & World Report. That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada ...


Gay News

Summit looking for BIPOC LGBTQ+ attendees 2021-07-22
- Pride Action Tank (PAT) and AIDS Foundation Chicago (AFC) will co-host "Co-Creating Futures: A BIPOC LGBTQ+ Policy & Practices Summit," starting virtually on Saturday, July 31, 11 a.m.-3:30 p.m. CT. According to the event's webpage, "T ...


Gay News

30th Annual 2021 AIDS Run & Walk Chicago to benefit 25 groups, AIDS Foundation Chicago 2021-07-13
--From a press release - CHICAGO — Now in its 30th year, AIDS Run & Walk Chicago returns to Soldier Field on Saturday, October 2 to support individuals living with and vulnerable to HIV/AIDS and other chronic illnesses. AIDS Run & ...


Gay News

NATIONAL Spa incident, N.J. items, AIDS gala, Tenn. lawsuits 2021-07-11
- Tensions rose between protesters and counterprotesters in Los Angeles over a spa incident involving a transgender woman, The Hill reported. Recently, a cisgender woman complained to staff at Wi Spa in Koreatown after a transgender woman ...


Gay News

ALMA, AFC host Latino/a/x-focused COVID-19 grand rounds virtual presentation 2021-07-08
- Association of Latino/as/x Motivating Action (ALMA) and AIDS Foundation Chicago (AFC) hosted a "COVID-19 Grand Rounds—Systemic Racism and Health Disparities: The Impact of COVID-19 on Latino/a/x populations" virtual presentation July ...


Gay News

Gilead requests approval of twice-a-year HIV medication 2021-07-02
- Biopharmaceutical company Gilead Sciences recently submitted a new drug application to the U.S. Food and Drug Administration—and it's for the drug lenacapavir, a long-acting HIV inhibitor that is under clinical ...


 



Copyright © 2021 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS






Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.